Investigation of the Synergic Effect of the Colistin/Sulbactam Combination in Carbapenem-Resistant Acinetobacter baumannii complex Strains with Time-Kill and Checkerboard Methods

被引:0
|
作者
Kilbas, Imdat [1 ]
Hatipoglu, Huseyin [1 ]
Kilic, Umit [1 ]
Kahraman Kilbas, Elmas Pinar [2 ]
Koroglu, Mehmet [1 ]
Altindis, Mustafa [1 ]
机构
[1] Sakarya Univ, Dept Med Microbiol, Fac Med, Sakarya, Turkey
[2] Fenerbahce Univ, Vocat Sch Hlth Serv, Dept Med Lab Tech, Istanbul, Turkey
来源
FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI | 2021年 / 26卷 / 01期
关键词
Acinetobacter baumannii; Colistin; Sulbactam; Synergy; Time-kill; Checkerboard; MULTIDRUG-RESISTANT; COLISTIN; SULBACTAM; MEROPENEM; EFFICACY; EPIDEMIOLOGY; MECHANISMS; IMIPENEM;
D O I
10.5578/flora.20219916
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Introduction: Infections caused by carbapenem-resistant Acinetobacter strains have become very common in recent years, and the most frequently used medicinal treatment is colistin. Combination treatments should also be applied to prevent development of resistance to colistin. This study examines the in vitro synergic effect of the colistin/sulbactam combination in carbapenem-resistant Acinetobacter strains with the time-kill and checkerboard methods. Materials and Methods: Twenty carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex strains, which were isolated from various clinical samples, were included in this study. Strains were identified with mass spectrometry, and antibiotic sensitivity results were determined with the VITEK 2 (R) system. The in vitro effect and synergic activity of the colistin, sulbactam, and colistin/sulbactam combination on the carbapenem-resistant strains were determined using the time-kill and checkerboard methods. Seventeen strains were examined with the time-kill method, and twenty strains were examined using the checkerboard method. The fractional inhibitory concentration index of strains was calculated for detection of synergic effect. Results: Using the time-kill method applied on the colistin/sulbactam combination showed that the combination had a synergic effect on all 17 strains, while sulbactam alone did not have a bactericidal effect in the studied concentrations. When applying the checkerboard method, it was determined that the colistin/sulbactam combination had a synergic effect on 17 of the strains (85%) and an additive effect on 3 strains (15%), sulbactam had a low effect alone (15%), and colistin was effective on all strains. Conclusion: Study results indicated that the colistin/sulbactam combination had a high level of synergic effect on all studied strains using both methods.
引用
收藏
页码:151 / 162
页数:12
相关论文
共 50 条
  • [11] A New Twist: The Combination of Sulbactam/Avibactam Enhances Sulbactam Activity against Carbapenem-Resistant Acinetobacter baumannii (CRAB) Isolates
    Pasteran, Fernando
    Cedano, Jose
    Baez, Michelle
    Albornoz, Ezequiel
    Rapoport, Melina
    Osteria, Jose
    Montana, Sabrina
    Le, Casin
    Ra, Grace
    Bonomo, Robert A.
    Tolmasky, Marcelo E.
    Adams, Mark
    Corso, Alejandra
    Ramirez, Maria Soledad
    ANTIBIOTICS-BASEL, 2021, 10 (05):
  • [12] In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii
    Song, Joon Young
    Kee, Sae Yoon
    Hwang, In Sook
    Bin Seo, Yu
    Jeong, Hye Won
    Kim, Woo Joo
    Cheong, Hee Jin
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (02) : 317 - 322
  • [13] Semi-mechanistic PK/PD modelling of meropenem and sulbactam combination against carbapenem-resistant strains of Acinetobacter baumannii
    Mohd Sazlly Lim, Sazlyna
    Heffernan, Aaron J.
    Zowawi, Hosam M.
    Roberts, Jason A.
    Sime, Fekade B.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2021, 40 (09) : 1943 - 1952
  • [14] In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia
    Cikman, Aytekin
    Gulhan, Baris
    Aydin, Merve
    Ceylan, Mehmet Resat
    Parlak, Mehmet
    Karakecili, Faruk
    Karagoz, Alper
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2015, 12 (09): : 695 - 700
  • [15] IN VITRO ACTIVITY OF COLISTIN OR SULBACTAM IN COMBINATION WITH FOSFOMYCIN OR IMIPENEM AGAINST CLINICAL ISOLATES OF CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII PRODUCING OXA-23 CARBAPENEMASES
    Santimaleeworagun, Wichai
    Wongpoowarak, Payom
    Chayakul, Pantip
    Pattharachayakul, Sutthiporn
    Tansakul, Pimpimon
    Garey, Kevin W.
    SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2011, 42 (04) : 890 - 900
  • [16] Effect of colistin-tigecycline combination on colistin-resistant and carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii
    Park, Suyeon
    Jin, Yanhong
    Ko, Kwan Soo
    MICROBIOLOGY SPECTRUM, 2025, 13 (02)
  • [17] Semi-mechanistic PK/PD modelling of meropenem and sulbactam combination against carbapenem-resistant strains of Acinetobacter baumannii
    Sazlyna Mohd Sazlly Lim
    Aaron J. Heffernan
    Hosam M. Zowawi
    Jason A. Roberts
    Fekade B. Sime
    European Journal of Clinical Microbiology & Infectious Diseases, 2021, 40 : 1943 - 1952
  • [18] Semimechanistic Pharmacokinetic/Pharmacodynamic Modeling of Fosfomycin and Sulbactam Combination against Carbapenem-Resistant Acinetobacter baumannii
    Lim, Sazlyna Mohd Sazlly
    Heffernan, Aaron J.
    Roberts, Jason A.
    Sime, Fekade B.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (05)
  • [19] Synergistic Activities of Colistin Combinations with Meropenem, Sulbactam, Minocycline, Disodium Fosfomycin, or Vancomycin Against Different Clones of Carbapenem-Resistant Acinetobacter baumannii Strains
    Sertcelik, Ahmet
    Baran, Irmak
    Akinci, Esragul
    Mumcuoglu, Ipek
    Bodur, Hurrem
    MICROBIAL DRUG RESISTANCE, 2020, 26 (05) : 429 - 433
  • [20] In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumannii
    Abdul-Mutakabbir, Jacinda C.
    Yim, Juwon
    Nguyen, Logan
    Maassen, Philip T.
    Stamper, Kyle
    Shiekh, Zain
    Kebriaei, Razieh
    Shields, Ryan K.
    Castanheira, Mariana
    Kaye, Keith S.
    Rybak, Michael J.
    ANTIBIOTICS-BASEL, 2021, 10 (07):